AVANIR PHARMACEUTICALS
10-K405, EX-23.1, 2000-12-21
PHARMACEUTICAL PREPARATIONS
Previous: AVANIR PHARMACEUTICALS, 10-K405, EX-21.1, 2000-12-21
Next: AVANIR PHARMACEUTICALS, 10-K405, EX-27.1, 2000-12-21



<PAGE>   1

                                                                    Exhibit 23.1


INDEPENDENT AUDITORS' CONSENT

AVANIR Pharmaceuticals:

We consent to the incorporation by reference in Registration Statements Nos.
33-71276, 33-94370, 333-83089, 333-84183 and 333-38094 on Form S-8 and
Registration Statements Nos. 33-49082, 33-76094, 333-24549, 333-76641,
333-77925, 333-31442, 333-32776, 333-34958, and 333-35934 on Form S-3 of AVANIR
Pharmaceuticals of our report dated December 15, 2000, appearing in this Annual
Report on Form 10-K of AVANIR Pharmaceuticals for the year ended September 30,
2000.


DELOITTE & TOUCHE LLP

San Diego, California
December 21, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission